Correlation Between Gilead Sciences and GlaxoSmithKline PLC
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and GlaxoSmithKline PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and GlaxoSmithKline PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and GlaxoSmithKline PLC ADR, you can compare the effects of market volatilities on Gilead Sciences and GlaxoSmithKline PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of GlaxoSmithKline PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and GlaxoSmithKline PLC.
Diversification Opportunities for Gilead Sciences and GlaxoSmithKline PLC
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and GlaxoSmithKline is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and GlaxoSmithKline PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlaxoSmithKline PLC ADR and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with GlaxoSmithKline PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlaxoSmithKline PLC ADR has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and GlaxoSmithKline PLC go up and down completely randomly.
Pair Corralation between Gilead Sciences and GlaxoSmithKline PLC
Given the investment horizon of 90 days Gilead Sciences is expected to under-perform the GlaxoSmithKline PLC. But the stock apears to be less risky and, when comparing its historical volatility, Gilead Sciences is 1.06 times less risky than GlaxoSmithKline PLC. The stock trades about -0.19 of its potential returns per unit of risk. The GlaxoSmithKline PLC ADR is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 4,234 in GlaxoSmithKline PLC ADR on January 25, 2024 and sell it today you would lose (148.00) from holding GlaxoSmithKline PLC ADR or give up 3.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Gilead Sciences vs. GlaxoSmithKline PLC ADR
Performance |
Timeline |
Gilead Sciences |
GlaxoSmithKline PLC ADR |
Gilead Sciences and GlaxoSmithKline PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gilead Sciences and GlaxoSmithKline PLC
The main advantage of trading using opposite Gilead Sciences and GlaxoSmithKline PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, GlaxoSmithKline PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlaxoSmithKline PLC will offset losses from the drop in GlaxoSmithKline PLC's long position.Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |